These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20585342)

  • 1. Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.
    Kiefer F; Witt SH; Frank J; Richter A; Treutlein J; Lemenager T; Nöthen MM; Cichon S; Batra A; Berner M; Wodarz N; Zimmermann US; Spanagel R; Wiedemann K; Smolka MN; Heinz A; Rietschel M; Mann K
    Pharmacogenomics J; 2011 Oct; 11(5):368-74. PubMed ID: 20585342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in the atrial natriuretic peptide transcription factor GATA4 modulates amygdala responsiveness in alcohol dependence.
    Jorde A; Bach P; Witt SH; Becker K; Reinhard I; Vollstädt-Klein S; Kirsch M; Hermann D; Charlet K; Beck A; Wimmer L; Frank J; Treutlein J; Spanagel R; Mann K; Walter H; Heinz A; Rietschel M; Kiefer F
    Biol Psychiatry; 2014 May; 75(10):790-7. PubMed ID: 24314346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
    Snyder JL; Bowers TG
    Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.
    Kiefer F; Jahn H; Otte C; Demiralay C; Wolf K; Wiedemann K
    J Psychiatr Res; 2005 Sep; 39(5):545-51. PubMed ID: 15992564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
    Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
    Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA4 variant interaction with brain limbic structure and relapse risk: A voxel-based morphometry study.
    Zois E; Vollstädt-Klein S; Hoffmann S; Reinhard I; Bach P; Charlet K; Beck A; Treutlein J; Frank J; Jorde A; Kirsch M; Degenhardt F; Walter H; Heinz A; Kiefer F
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1431-1437. PubMed ID: 27397865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
    Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
    Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.
    Donoghue K; Elzerbi C; Saunders R; Whittington C; Pilling S; Drummond C
    Addiction; 2015 Jun; 110(6):920-30. PubMed ID: 25664494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of GATA4 sequence variation with alcohol dependence.
    Karpyak VM; Winham SJ; Biernacka JM; Cunningham JM; Lewis KA; Geske JR; Colby CL; Abulseoud OA; Hall-Flavin DK; Loukianova LL; Schneekloth TD; Frye MA; Heit JA; Mrazek DA
    Addict Biol; 2014 Mar; 19(2):312-5. PubMed ID: 22862823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
    Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
    Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
    Dahl H; Hammarberg A; Franck J; Helander A
    Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological treatment of alcohol dependence. Acamprosate and naltrexone offer new approach].
    Berglund M; Balldin J; Bendtsen P; Borg S; Franck J; Gustafsson L; Halldin J; Månsson M; Nilsson LH; Stolt G; Willander A
    Lakartidningen; 1997 Jul; 94(30-31):2645-8. PubMed ID: 9273426
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical predictors of outcome from an Australian pharmacological relapse prevention trial.
    Morley KC; Teesson M; Sannibale C; Baillie A; Haber PS
    Alcohol Alcohol; 2010; 45(6):520-6. PubMed ID: 20952764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
    Kiefer F; Helwig H; Tarnaske T; Otte C; Jahn H; Wiedemann K
    Eur Addict Res; 2005; 11(2):83-91. PubMed ID: 15785069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications for treating alcohol dependence.
    Williams SH
    Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.